Index. Note: Page numbers of article titles are in boldface type.
|
|
- Douglas Gaines
- 5 years ago
- Views:
Transcription
1 Index Note: Page numbers of article titles are in boldface type. A ABCG2 gene, in gout, Acetaminophen, for CPP crystal deposition, 347 ACTH (corticotropin), for gout, , 383 ADAMTS proteins, in cartilage damage, 297 Age factors, in CPP crystal deposition, 180 Alcohol consumption, as gout risk factor, , 286, 359 ALDH2 gene, in gout, 286 Allopurinol, for gout, 254, , , 376 American College of Rheumatology, gout guidelines of, 330 Anakinra for BCP crystal deposition, 348 for gout, 301, , ANKH gene, in CPP crystal deposition, , 209 Antihypertensive drugs, as gout risk factor, 169 Antioxidants, urate as, 262 Arhalofenate (MBX-102), for gout, 380 ARIC (Atherosclerosis Risk in Communities), 157, 163, , 262 Arthritis BCP. See Basic calcium phosphate crystal deposition. CPP. See Calcium pyrophosphate crystal deposition. degenerative. See Osteoarthritis. gouty, rheumatoid, CPP crystal deposition and, Arthrocentesis for BCP crystal deposition, for CPP crystal deposition, 347 Arthropathy BCP. See Basic calcium phosphate crystal deposition. CPP. See Calcium pyrophosphate crystal deposition. hydroxyapatite, , 245 Aspirin, gout and, 169 Atherosclerosis chondrocalcinosis and, gout and, Atherosclerosis Risk in Communities (ARIC), 157, 163, , 262 Aura, gouty, 195 B Baker cyst, in gout, 196 Barbotage, for BCP crystal deposition, Rheum Dis Clin N Am 40 (2014) rheumatic.theclinics.com X/14/$ see front matter ª 2014 Elsevier Inc. All rights reserved.
2 390 Index Basic calcium phosphate crystal deposition asymptomatic, 210 atherosclerosis and, calcification formation in, clinical manifestations of, , comorbidities with, 208 crystal structure in, 312 diagnosis of, , , 223, 244 epidemiology of, forms of, 348 imaging for, 223, pathogenicity of, risk factors for, 208 structural consequences of, treatment of, BCP. See Basic calcium phosphate. Benzbromarone, for gout, Body mass index, high, as gout risk factor, , 359 Bone erosion of, in BCP crystal deposition, in calcium crystal deposition, 314 in gout, 232 ultrasonography for, 233 remodeling of, in gout, Bone morphogenic proteins, in bone remodeling, Boston Nurse s Health Study, 323 Bursitis, in calcium crystal deposition, 314 C Calcific periarthritis, , , 350 Calcific tendinitis, acute, in calcium crystal deposition, 314 Calcium pyrophosphate crystal deposition acute, , , arthritis in, , 215 asymptomatic, 210, 214 atherosclerosis and, calcification in, chronic, classification of, 178 clinical manifestations of, , , , 344 comorbidities with, 208, 263, computed tomography for, 241 crystal structure in, 209, 312 diagnosis of, , epidemiology of, , 344 familial, imaging for, 223, , 245,
3 joints affected by, 178 pathogenicity of, radiography for, risk factors for, , stages of, 346 structural consequences of, treatment of, acute, long-term, ultrasonography for, 241 Canakinumab for CPP crystal deposition, 347 for gout, 301, , Cardiovascular disease, gout and, , 359 Cardiovascular Health Study, 258 Cartilage, damage of, in gout, Caspase inhibitors, for gout, CD73, in CPP crystal deposition, 209 Cerebrovascular disease, gout and, Cervical myelopathy, compressive, in CPP crystal deposition, China, gout in, 160 Chondrocalcinosis, atherosclerosis and, clinical manifestations of, 344 imaging for, Chondrocytes, in gout, Coffee, gout and, 164 Colchicine for CPP crystal deposition, for gout, , 338 Cold therapy, for gout, 330 Combination therapy, for gout, Computed tomography for BCP crystal deposition, , 220, 223 for bone erosion, 293 for calcium crystal deposition, , 320 for CPP crystal deposition, 223, 241, for crowned dens syndrome, 218 for gout, , 244, 292 for hydroxyapatite arthropathy, for tendon evaluation, 299 Congestive heart failure, gout and, 256, 264 Coronary heart disease chondrocalcinosis and, gout and, , 264 Corticosteroids for CPP crystal deposition, for gout, 331, Corticotropin (ACTH), for gout, , 383 CPP. See Calcium pyrophosphate. Crowned dens syndrome, 210, , 241 Index 391
4 392 Index Crystal deposition diseases. See Basic calcium phosphate crystal deposition; Calcium pyrophosphate crystal deposition. Cyclosporine, as gout risk factor, 359 Cytokines, in bone erosion, D Destructive arthropathy, in CPP crystal deposition, Diabetes mellitus BCP crystal deposition in, gout and, 261, 265, 359 Dietary factors, in gout, , 359 Diuretics, as gout risk factor, 169, 286, 359 DKK genes, in bone remodeling, Double-contour sign, in gout, 233 Dual-energy computed tomography for bone erosion, 293 for calcium crystal deposition, , 320 for gout, , 244 for tendon evaluation, 299 Duloxetine, for CPP crystal deposition, 348 E Elderly persons, CPP crystal deposition in, 180 Endocrine disorders, CPP crystal deposition and, Endothelium, urate effects on, ENPP-1 protein, in CPP crystal deposition, 209 Environmental factors, in gout, Etoricoxib, for gout, 334 European League Against Rheumatism crystal deposition terminology of, 208 gout guidelines of, 330 propositions of, 215 Extracorporeal shock wave therapy, for BCP crystal deposition, F Febuxostat, for gout, Fenofibrate, for gout, 366 First metatarsophalangeal joint, gout in, 194 Four-joint screening, for gout, 202 Framingham Heart Study, 156, 161, 163, , 255, 315 Frediani classification, of CPP crystal deposition, 223 French Society of Arthroscopy, Fructose intake, as gout risk factor, , 286, 359 G Gärtner and Heyer classification, of BCP crystal deposition, GCKR gene, in gout,
5 Gender differences, in CPP crystal deposition, 180 General Practice Research Database, 160 Genetic factors in CPP crystal deposition, , in gout, environmental factors interacting with, genome-wide association studies in, , 287 mechanisms of, Genetics and Osteoarthritis and Lifestyle (GOAL) study, 319, 323 Genome-wide association studies, in gout, , 287 Gitelman syndrome, Glycolytic genes, in gout, GOAL (Genetics and Osteoarthritis and Lifestyle) study, 319, 323 Gout acute, animal models for, 301 asymptomatic, classification of, 202 clinical manifestations of, comorbidities with, computed tomography for, CPP crystal deposition and, definition of, 193 description of, 155 diagnosis of, differential diagnosis of, 203 dual-energy computed tomography for, epidemiology of, genetic factors in, imaging for, , 244 incidence of, joints involved in, magnetic resonance imaging for, natural history of, osteoarthritis and, 300 pathology of, 236, persistent (nonacute), prevalence of, 160 prevention of, prodromal symptoms of, 195 radiography for, risk factors for, modification of, stages of, 194 structural joint damage in, treatment of, emerging therapies for, nonadherence to, 361 nonpharmacologic, pharmacologic, serum urate goals in, 361 strategies for, Index 393
6 394 Index Gout (continued) symptom reduction in, 200 to prevent joint damage, ultrasonography for, H Hand, calcific periarthritis of, 350 Health Professionals Follow-up Study, 156, , 163, 165, , 262 Heart failure, gout and, 256, 264 Hemarthrosis, in CPP crystal deposition, 219 Hemochromatosis, CPP crystal deposition and, , Hemorrhagic shoulder of the elderly, Huntington disease, gout and, 263, 265 Hydroxyapatite, in BCP crystal deposition, Hydroxyapatite arthropathy, imaging for, , 245 Hyperdyslipidemia, as gout risk factor, Hyperparathyroidism, CPP crystal deposition and, 183, Hypertension, gout and, , , 264, 359 Hyperuricemia, as gout precursor, comorbidities with, definition of, 252 genetic factors in, treatment of, Hypomagnesemia, CPP crystal deposition and, 183 Hypophosphatasia, CPP crystal deposition and, 183, 266 Hypothyroidism, CPP crystal deposition and, 182 I Ice therapy, for gout, 330 Imaging, See also specific modalities. Indomethacin, for gout, 334 Insulin resistance, gout and, 261, 264 Interleukin(s) in bone erosion, in calcium crystal deposition, inhibitors of, for gout, , 331, , Iowa Women s Health Study, 323 J John Hopkins Precursor Study, 160 Joint(s) in CPP crystal deposition, 178 in gout, , bone erosion in, cartilage damage in, future research directions in, screening of, 202 tendon involvement in,
7 Index 395 K Kidney disease, gout and, 170, , 264, 359 Kinmen Study from Taiwan, 161 Knee alignment of, CPP crystal deposition and, 182 osteoarthritis of, 216 L Lavage, for BCP crystal deposition, Lesinurad (RDEA594), for gout, Levotofisopam, for gout, Lifestyle changes, for gout, Longus colli muscle, BCP deposition in, 212 Losartan, for gout, 366 LRP2 gene, in gout, 286 Lumbar canal stenosis, in CPP crystal deposition, M Macrophages, in bone erosion, 296 Magnetic resonance imaging for BCP crystal deposition, , 223 for bone erosion, 293 for calcium crystal deposition, , 317, 320 for CPP crystal deposition, 223, for crowned dens syndrome, 218 for gout, , 244 for hydroxyapatite arthropathy, for tendon evaluation, 299 Matrix metalloproteinases, in cartilage damage, 298 Medications, as gout risk factor, , 359 Melanocortin, for gout, 383 Meniscectomy, CPP crystal deposition and, 182 Mesotherapy, for BCP crystal deposition, 350 Metabolic syndrome, as gout risk factor, , , 264 Microscopy for CPP crystal deposition, for monosodium urate crystals, 202 Milwaukee shoulder syndrome, , 314, MLXIPL gene, in gout, Monosodium urate crystals, 193, , bone erosion and, genetic factors in, in cartilage damage, osteoarthritis and, 300 Multiple sclerosis, gout and, 263 Myelopathy, cervical, compressive, N Naproxen, for gout, 334 Neck pain, in BCP crystal deposition, 212
8 396 Index Needling treatment, for BCP crystal deposition, Nephrolithiasis, gout and, 259 Neurologic disorders, gout and, , 265 Neuropathy, in calcium crystal deposition, 313 Neutrophils, in bone erosion, 295 New Zealand, gout in, 160 NFAT5 gene, in gout, NLRP-3 inflammasome, in gout, Nonsteroidal anti-inflammatory drugs for BCP crystal deposition, 348, 350 for CPP crystal deposition, 347 for gout, , 338 Normative Aging Study, 161 Nosologic diagnosis, of gout, Nurses Health Study, 156, O OAT4 gene, in gout, 286 Obesity, as gout risk factor, , 359 Obstructive sleep apnea, gout and, Osteoarthritis as gout risk factor, 170 BCP crystal deposition and, 216, 351 calcium crystal deposition and, CPP crystal deposition and, 181, 216, 263, 265 gout and, 300 imaging for, Osteoblasts, in bone erosion, 295 Osteoclasts, in bone erosion, Osteophytes, in bone remodeling, Osteoprotegerin in bone erosion, 294 in calcium crystal deposition, 323 Oxyphenbutazone, for gout, 337 P Parkinson disease, gout and, , 265 PDZK1 gene, in gout, Pegloticase, for gout, , , 376 Periarthritis, in calcium crystal deposition, 314 Peripheral arterial disease, gout and, Peroxynitrite, urate interactions with, 262 Physical therapy for BCP crystal deposition, 348 for CPP crystal deposition, 347 PiT protein, in CPP crystal deposition, 209 PKLR gene, in gout, Podagra, 194 Polarized microscopy, for CPP crystal deposition,
9 Index 397 Prednisolone, for gout, 335 Prednisone, for gout, 335 PRKAG2 gene, in gout, Probenecid, for gout, Prostaglandins, in bone erosion, 295 Proteases, in BCP crystal deposition, 352 PRPSAP1 gene, in gout, 285 Pseudogout, 263, 312. See also specific disorders. Pseudopodagra, 184 Purine dietary, in gout, inborn errors of metabolism of, 280 R Radial shock wave therapy, for BCP crystal deposition, 349 Radiography for BCP crystal deposition, 212, for calcium crystal deposition, , for CPP crystal deposition, 222, , for gout, 202, , 244, 293 for hydroxyapatite arthropathy, RANK and RANKL, in bone erosion, 294 RENAAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) trial, 259 Renal Data System, 258 Rest, for gout, 330 Rheumatoid arthritis, CPP crystal deposition and, Rilonacept, for gout, 301, , Risk factors, for gout alcohol consumption, , 286, 359 diabetes mellitus, 261, 359 dietary, , 286, 359 hyperdyslipidemia, kidney disease, 170, , 359 medications, , 359 metabolic syndrome, , obesity, , 359 Rochester Epidemiology Project, 161 S Sex differences, in CPP crystal deposition, 180 Shoulder BCP crystal deposition in, Milwaukee, , 314, SLC2A9 gene, in gout, 283, SLC17A1 gene, in gout, 287 SLC22A12 gene, in gout, Spinal cord compression, in calcium crystal deposition, 313 Spine, CPP crystal deposition in,
10 398 Index Stones, urinary tract, gout and, 259 Stroke, gout and, , 264 Sugar consumption, gout and, 165 Sulfinpyrazone, for gout, Sulindac, for gout, 334 Synovial fluid analysis in CPP crystal deposition, , 345 in gout, 202 Synovitis, in calcium crystal deposition, 214, 312 T T lymphocytes, in bone erosion, 296 Tendons, in gout, Tenosynovitis, in calcium crystal deposition, 313, THIN (The Health Improvement Network), 157, 161, 163, 166, TNAP protein, in CPP crystal deposition, 209 Tophi, computed tomography for, dual-energy computed tomography for, in bone erosion, magnetic resonance imaging for, radiography for, , 293 resolution of, ultrasonography for, Triamcinolone, for gout, 335 Tumor lysis syndrome, 259 U Ulodesine (BCX4208), for gout, 378 Ultrasonography for BCP crystal deposition, 220 for CPP crystal deposition, , 241, , for gout, , 244 for hydroxyapatite arthropathy, for tendon evaluation, 299 Ultrasound therapy, for BCP crystal deposition, 348 Urate antioxidant activity of, urate as, 262 metabolism of, Urate anion transporter 1, Uricase, recombinant (pegloticase), for gout, , , 376 Uricosic agents, for gout, Urolithiasis, gout and, 259 V Vienna Health Screening Project, 258 Vitamin C, gout and, 165
11 Index 399 W Wilson disease, CPP crystal deposition and, 182, 266 Wnt signaling molecules, in bone remodeling, X Xanthine oxidase, in heart failure, 256
Crystal induced arthropathies. Dr. Amitesh Aggarwal
Crystal induced arthropathies Dr. Amitesh Aggarwal 1 Crystal induced Arthropathies Gout Pseudogout Debilitating illnesses; Recurrent episodes of pain and joint inflammation; Formation and deposition of
More informationGOUT & PSEUDOGOUT OPSC 2018 HOWARD L. FEINBERG, D.O., F.A.C.O.I.., F.A.C.R.
GOUT & PSEUDOGOUT OPSC 2018 HOWARD L. FEINBERG, D.O., F.A.C.O.I.., F.A.C.R. Everything in excess is opposed by nature Eunuchs do not take the gout, nor become bald. GOUT Hyperuricemia is not gout Gout
More informationCrystal-Induced Arthritis. Rajesh Kataria, D.O. Southern Ohio Rheumatology
Crystal-Induced Arthritis Rajesh Kataria, D.O. Southern Ohio Rheumatology Disclosures Speaker: Rajesh Kataria, D.O. Relationships with commercial interests: Speakers Bureau - Horizon Presentation will
More informationCOPYRIGHT. Update in Internal Medicine December 4, 2016
Update in Internal Medicine December 4, 2016 Fadi Badlissi, MD, MSc Director of the Musculoskeletal Medicine Unit The Orthopedic Department & Rheumatology Division Beth Israel Deaconess Medical Center
More informationGout -revisited. Shrenik Shah
Gout -revisited Shrenik Shah definition Monosodium urate (MSU) crystal deposition episodic and later persistent joint inflammation and tophi All MSU crystal deposition- broader definition EULAR- European
More informationGout Hanan Abdel Rehim
Review article 35 Gout Hanan Abdel Rehim Department of Internal Medicine, Kasr-Al Aini School of Medicine, Cairo University, Cairo, Egypt Correspondence to Hanan Abdel Rehim, MD, 11 Ismaiel Wahby Street,
More informationGout 2.0. Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy
Gout 2.0 Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy Case 48 year old man presents with swollen, painful left toe that started overnight. Didn t hurt when he went to bed. No
More informationGout. Crystal deposition disease: Imaging perspectives. Crystal associated arthropathies. Clinical Stages of Gout 07/06/60
Crystal associated arthropathies Crystal deposition disease: Imaging perspectives Warapat Virayavanich, MD Ramathibodi hospital, Mahidol University Commonly seen arthropathy MSU (gout) CPPD HADD Uncommon
More informationGout A rapid review. Jeremy Jones
Gout A rapid review Jeremy Jones The Hyperuricemia Cascade Dietary purines Tissue nucleic acids Urate Endogenous purine synthesis Overproduction Hyperuricemia Underexcretion Silent tissue deposition Gout
More information395: Gout and Other Crystal-Associated Arthropathies
Harrison's Principles of Internal Medicine, 19e > 395: Gout and Other Crystal-Associated Arthropathies H. Ralph Schumacher; Lan X. Chen INTRODUCTION The use of polarizing light microscopy during synovial
More informationOBJECTIVES GOUT GOUTY INFLAMMATION 6/10/2016 GOUT INCIDENCE AND PREVALENCE MONOSODIUM URATE CRYSTAL DEPOSITION DISEASE
GOUT Lisa Talbert, MD Family Medicine Update June 15, 2016 OBJECTIVES To be familiar with the clinical presentation and pathophysiology of gouty arthritis Be able to incorporate current guidelines when
More informationPodcast (Video Recorded Lecture Series): Gout for the USMLE Step One Exam. Howard J. Sachs, MD
Podcast (Video Recorded Lecture Series): Gout for the USMLE Step One Exam Howard J. Sachs, MD www.12daysinmarch.com Email: Howard@12daysinmarch.com Podcast (Video Recorded Lecture Series): Gout for the
More information1. To review the diagnosis of gout and its differential. 2. To understand the four stages of gout
Objectives 1. To review the diagnosis of gout and its differential GOUT 2. To understand the four stages of gout 3. To develop an approach for the acute treatment of gout Anthony Lim 9/13/12 Cycle 3 4.
More informationUpdate on Gout for GPs
Update on Gout for GPs Dr Patrick Kiely PhD FRCP Consultant Physician and Rheumatologist St George s, London 2/3 1/3 Gut bacteria have uricase Chronic erosive arthropathy Clinical spectrum Making the diagnosis
More informationGout Treatment Guidelines
Gout Treatment Guidelines Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a foundation of an excess body burden of uric acid, manifested in part by hyperuricemia,
More informationFor more information about how to cite these materials visit
Author(s): Seetha Monrad, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More informationLecture 8 Gout Hinch. Pathogenesis of acute attacks
Gout: disease characterized by deposition of monosodium crystals in soft tissues (cartilage, tendons, bursa) recurrent episodes of acute joint pain & inflammation Pathogenesis of acute attacks Epidemiology:
More informationA Patient s Guide to Gout. Foot and Ankle Center of Massachusetts, P.C.
A Patient s Guide to Gout Welcome to Foot and Ankle Center of Massachusetts, where we believe in accelerating your learning curve with educational materials that are clearly written and professionally
More informationRheumatology Cases for the Internist
Rheumatology Cases for the Internist Marc C. Hochberg, MD, MPH Professor of Medicine Head, Division of Rheumatology and Clinical Immunology Vice Chair, Department of Medicine University of Maryland School
More informationGOUT. Dr Krishnan Baburaj West herts NHS Trust
GOUT Dr Krishnan Baburaj West herts NHS Trust podagra Gout A disease of kings, the king of diseases History Louis XIV Emperor Augustus Henry VIII Introduction Gout an inflammatory arthritic condition that
More informationRheumatoid arthritis, seronegative spondylarthritides and gout. György Nagy
Rheumatoid arthritis, seronegative spondylarthritides and gout György Nagy Dec 4, 2017 Rheumatoid arthritis Rheumatoid arthritis Chronic, progressive, autoimmune disorder of the joints with extra-articular
More informationEnhanced Primary Care Pathway: Gout
Enhanced Primary Care Pathway: Gout 1. Focused summary of gout relevant to primary care Significance: Gout is a chronic, progressive, inflammatory disease requiring appropriate long-term management. Gout
More informationArthritis due to deposition diseases: differential diagnosis in conventional radiology
Arthritis due to deposition diseases: differential diagnosis in conventional radiology Poster No.: C-1599 Congress: ECR 2016 Type: Educational Exhibit Authors: A. P. Pissarra, R. R. Domingues Madaleno,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abatacept, 239 Acetaminophen, 194 Acupuncture, 205 Adalimumab, 187, 226, 239, 247 Allopurinol, for gout, 188 American College of Rheumatology,
More informationGout. Edward Roddy, 1 Christian D Mallen, 1 Michael Doherty 2 CLINICAL REVIEW
Gout Edward Roddy, 1 Christian D Mallen, 1 Michael Doherty 2 1 Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University, Keele ST5 5BG, UK 2 Academic Rheumatology, University
More informationMicrocrystal Arthritis: From Gout To Osteoarthritis Vilnius, Lithuania,
Microcrystal Arthritis: From Gout To Osteoarthritis Vilnius, Lithuania, 22.9.2017 Prof Alexander So Service of Rheumatology CHUV and UNIL, Lausanne, Switzerland 2 Happy anniversary 3 4 Disclosures Consultant:
More informationCHAPTER:2 GOUT. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
CHAPTER:2 GOUT BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY DEFINITION Gout is defined as a peripheral arthritis, resulting from the deposition of MSU crystals
More information4 2 Osteoarthritis 1
Osteoarthritis 1 Osteoarthritis ( OA) Osteoarthritis is a chronic disease and the most common of all rheumatological disorders. It particularly affects individuals over the age of 65 years. The prevalence
More informationTHE BURDEN OF SUBCLINICAL SYNOVITIS IN GOUT
THE BURDEN OF SUBCLINICAL SYNOVITIS IN GOUT PRIYA CHOWALLOOR, MBBS, FRACP This thesis is presented for the degree of Masters of Clinical Research of The University of Western Australia SCHOOL OF MEDICINE
More informationAn update on the management of gout
An update on the management of gout 8 The management of gout involves treatment of an acute attack, lifestyle modification and urate lowering treatment to achieve a target serum urate level. Recent evidence
More informationPennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016
Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Gout and Pseudogout Wayne Blount MD Speaker has no disclosures
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abatacept, for rheumatoid arthritis, 789 Acetaminophen, for low back pain, 735 Acupuncture for fibromyalgia, 753 for low back pain, 738
More informationGOUT disease spectrum including
GOUT disease spectrum including *hyperuricemia, *recurrent attacks of acute arthritis associated with monosodium urate crystals in leukocytes found in synovial fluid, *deposits of monosodium urate crystals
More informationCurrent and Emerging Therapies for Gout Samya Mohammad, DO 1 Stephanie L. Giattino, MD 2 Robert T. Keenan, MD, MPH 1,*
Curr Treat Options in Rheum (2015) 1:143 155 DOI 10.1007/s40674-015-0015-6 Gout (A Gibofsky, Section Editor) Current and Emerging Therapies for Gout Samya Mohammad, DO 1 Stephanie L. Giattino, MD 2 Robert
More informationGOUT IN THE ELDERLY. Learning Objectives. Disclosure. Geriatric Grand Rounds. Geriatric Grand Rounds
Visit web sites: Tuesday, June 2, 2009 12:00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this event
More informationDrugs for Gout, osteoarthritis and osteoporosis
MMS Pharmacology Lecture 3 Drugs for Gout, osteoarthritis and osteoporosis Dr Sura Al Zoubi Revision Gout The term gout describes a disease spectrum including hyperuricemia, recurrent attacks of acute
More informationAcute hot swollen joint. Dr Edward Roddy Senior Lecturer in Rheumatology and Consultant Rheumatologist
Acute hot swollen joint Dr Edward Roddy Senior Lecturer in Rheumatology and Consultant Rheumatologist Acute monoarthritis: differential diagnosis Septic arthritis Crystal arthritis (gout, pseudogout) Haemarthrosis
More informationCase presentation. serum uric acid = 11.5 mg/dl 24-hour uric acid excretion = 300 mg
GOUT 55 y/o male 12 hours pain in my big toe & ankle went to bed last night feeling fine felt as if had broken toe this morning similar problems in right ankle & left wrist Case presentation lab studies
More informationGout- Treatment Updates. Harinder Singh, MD Rheumatology Mercy Internal Medicine Clinic Mason City, IA
Gout- Treatment Updates Harinder Singh, MD Rheumatology Mercy Internal Medicine Clinic Mason City, IA Gout Outline of purine metabolism: (1) amidophosphoribosyltransferase (2) hypoxanthine-guanine phosphoribosyltransferase
More informationACR Meeting November, 2012
ACR Meeting November, 212 Arhalofenate is a Novel Dual-Acting Agent with Uricosuric and Anti-Inflammatory Properties Yun-Jung Choi, Vanina Larroca, Annette Lucman, Vic Vicena, Noe Abarca, Tim Rantz, Brian
More informationELENI ANDIPA General Hospital of Athens G. Gennimatas
ELENI ANDIPA General Hospital of Athens G. Gennimatas Technological advances over the last years have caused a dramatic improvement in ultrasound quality and resolution An established imaging modality
More informationClinical Practice Guideline. Gout. Version
Clinical Practice Guideline Gout Version 1.1.2017 August 2017 Table of Contents Introduction...5 Stages of Gout...7 Asymptomatic Hyperuricemia... 7 Acute Intermittent Gout... 7 Advanced Gout... 8 Diagnosis...8
More informationMono-articular Joint Complaints
Mono-articular Joint Complaints Derrick J. Todd, M.D., Ph.D. Associate Physician Department of Rheumatology, Immunology, and Allergy Brigham and Women s Hospital Instructor of Medicine Harvard Medical
More informationGout. Clinical features Most commonly affects middle-aged males. It is an acute and usually relapsing selflimiting
Gout Gout is a syndrome caused by an inflammatory response to the formation of monosodium urate monohydrate crystals which develop secondary to hyperuricemia. Acute and chronic forms are recognized. Hyperuricemia
More informationDrugs Used to Treat Gout. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Drugs Used to Treat Gout Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Gout is a metabolic disease characterized by recurrent episodes of acute arthritis
More informationHow to Summary Record. Anatomical Site Code. Anatomical Site Code. Chapter XIII M00-M99 Musculoskeletal System & Connective Tissue.
How to Summary Record What Where When Infection Region Congenital Inflammation Level Infant Degeneration Medial/Lateral Juvenile Chapter XIII M00-M99 Musculoskeletal System & Connective Tissue Traumatic
More informationInflammation in OA. Osteoarthritis. Crystals found in synovial fluid. Calcium-containing crystals in OA 10/28/2013. I have no disclosures
Dublin Academic Medical Centre Dublin Academic Medical Centre How Do Calcium Crystals Induce Inflammation and Contribute to Osteoarthritis I have no disclosures Geraldine McCarthy MD, FRCPI Clinical Professor
More informationGout: Develop treatment plan in William Jones, MS, RPh
Gout: Develop treatment plan in 2013 William Jones, MS, RPh (wnjones49@cox.net) Objectives Describe acute gouty arthritis Tx Describe Tx of chronic gouty arthritis. Define the target serum uric acid concentration
More informationGout: Let s Be Crystal Clear. Dr. Philip A. Baer Seacourses Asia CME December 2017
Gout: Let s Be Crystal Clear Dr. Philip A. Baer Seacourses Asia CME December 2017 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or
More informationUpdate on the Management of Gout
Update on the Management of Gout Professor Anthony D Woolf Duke of Cornwall Department of Rheumatology Royal Cornwall Hospital, Truro, UK Peninsular Medical School Universities of Exeter and Plymouth People
More informationKelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition
Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition Firestein, G ISBN-13: 9781437717389 Table of Contents VOLUME I STRUCTURE AND FUNCTION OF BONE,
More informationRHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center
RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center What is Rheumatology? Medical science devoted to the rheumatic diseases
More informationIndex. Rheum Dis Clin N Am 32 (2006) Note: Page numbers of article titles are in boldface type.
Rheum Dis Clin N Am 32 (2006) 775 780 Index Note: Page numbers of article titles are in boldface type. A AACE (American Association of Clinical Endocrinologists), bone mineral density recommendations of,
More informationCurrent treatment options for acute and chronic gout
DRUG REVIEW n Current treatment options for acute and chronic gout Kelsey Jordan FRCP and Andrew Jeffries PGDip, MRCP Gout is the only curable form of arthritis, yet only a third of patients with chronic
More informationCase Report Refractory Gout Attack
Case Reports in Medicine Volume 2012, Article ID 657694, 4 pages doi:10.1155/2012/657694 Case Report Refractory Gout Attack Simone Fargetti, Claudia Goldenstein-Schainberg, Andressa Silva Abreu, and Ricardo
More informationOsteoarthritis. Rheumatology Update. Gout 1/17/2013
Osteoarthritis Rheumatology Update Richard Zweig, MD January, 2013 Degeneration of cartilage over time accompanied by increase in bone density and bone formation around the joint Risks include: aging,
More information3/2/2014. Got Gout? Get a Plumber. Objectives. Disclosures
Got Gout? Get a Plumber. Heidi Garcia, PA-C Department of Rheumatology Division of Internal Medicine Mayo Clinic Arizona 2013 MFMER slide-1 Objectives Recall some of the history of Gout. Describe the pathophysiology
More informationDisclosures. Ultrasonography. Conventional radiography (XR) Magnetic resonance imaging. Conventional CT 10/27/2013
What I can see in my gout patient that I couldn t before: the role of advanced imaging in gout diagnosis and monitoring Disclosures ND is supported by the Health Research Council of New Zealand I have
More informationNew Drug Evaluation: lesinurad tablet, oral
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationManaging Gout A Review of the Research for Adults
Managing Gout A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional* has said that you have gout. You are age 18 or
More informationEssence of the Revised Guideline for the Management of Hyperuricemia and Gout
Research and Reviews Essence of the Revised Guideline for the Management of Hyperuricemia and Gout JMAJ 55(4): 324 329, 2012 Hisashi YAMANAKA,* 1 The Guideline Revising Committee of Japanese Society of
More informationCopyright 2016 Wolters Kluwer Health, Inc. All rights reserved.
14 The Nurse Practitioner Vol. 41, No. 14 www.tnpj.com 2.5 CONTACT HOURS 2.5 CONTACT HOURS Gout An update on for primary care providers Abstract: This article discusses the current beliefs regarding the
More informationClinical Practice Guideline. Ultrasound in Rheumatological Settings. Version
Clinical Practice Guideline Ultrasound in Rheumatological Settings Version 1.1.2017 November 2017 Table of Contents Abbreviations...3 Introduction...4 Diagnostic Musculoskeletal Ultrasound...6 Definition
More informationDiagnosis and Management of Gout in 2011
October 18, 2011 Early and accurate gout diagnosis and disease management are essential. Making the clinical diagnosis takes into consideration the differential diagnosis supported by the use of clinical,
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 24 June 2009
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 24 June 2009 ADENURIC 80 mg, film-coated tablets B/28 (CIP code: 385 724-4) B/84 (CIP code: 572 820-3) ADENURIC 120
More informationThe Clinic a l Problem
T h e n e w e ngl a nd j o u r na l o f m e dic i n e Gout Tuhina Neogi, M.D., Ph.D. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various
More informationClinical Biochemistry department/ College of medicine / AL-Mustansiriyah University
Clinical Biochemistry department/ College of medicine / AL-Mustansiriyah University Dr. Ali al-bayati NUCLEOTIDE METABOLISM Lec. 3 The salvage pathway of purine synthesis Purines that result from the normal
More informationCrystal Deposition Disease and Psoriatic Arthritis
74 Crystal Deposition Disease and Psoriatic Arthritis Philip J. O Connor, MRCP, FRCR, FFSEM (UK) 1,2 1 Department of Radiology, Leeds Teaching Hospitals, Chapel Allerton Hospital, Leeds, United Kingdom
More informationRheumatology Review Update in Internal Medicine COPYRIGHT. Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center.
Rheumatology Review Update in Internal Medicine Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center Boston MA Case #1 True statement(s) regarding etanercept and leflunomide, for the treatment
More informationWORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 2464/03
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 2464/03 BEFORE: T. Carroll: Vice-Chair G.V. Stewart: Member Representative of Employers D. Gillies: Member Representative of Workers HEARING:
More informationGout basics. Update on Gout. Production of uric acid. Gout basics. Crystal induced inflammation. Gout calculator. The important role of ultrasound
Update on Gout The important role of ultrasound Cheung C Yue, M.D. Gout basics Hyperuricemia gout Over 5 years, 22% >9 mg/dl develop gout Man 3-4 times more than women Risks: thiazide, cyclosporin, low
More informationCost-effectiveness of lesinurad (Zurampic ) for the treatment of adult patients with gout
Cost-effectiveness of lesinurad (Zurampic ) for the treatment of adult patients with gout The NCPE has issued a recommendation regarding the cost-effectiveness of Lesinurad (Zurampic ) in combination with
More informationInitial Phase 3 Studies Results for Rilonacept in the Prevention of Gout Flares in Patients Initiating Uric Acid-lowering Therapy and the Treatment
Initial Phase 3 Studies Results for Rilonacept in the Prevention of Gout Flares in Patients Initiating Uric Acid-lowering Therapy and the Treatment of Patients in the Midst of an Acute Gout Attack Investor
More informationAdditional File 1. ICD9 Codes for chronic pain related diagnoses Dx Diagnosis Description Codes
Additional File 1. ICD9 Codes for chronic pain related diagnoses Dx Diagnosis Description Dx Diagnosis Description Codes Codes 327.52 Sleep related leg cramps 717 Old bucket handle tear of medial 333.84
More informationSpondyloarthritis: A Gouty Display
Spondyloarthritis: A Gouty Display Preetam Gongidi 1*, Shawn Gough-Fibkins 2 1. Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale, FL, USA 2. Broward General Medical Center,
More informationLesinurad in Combination With a Xanthine Oxidase Inhibitor for Treatment of Hyperuricemia Associated With Gout
Lesinurad in Combination With a Xanthine Oxidase Inhibitor for Treatment of Hyperuricemia Associated With Gout Briefing Document for the Arthritis Advisory Committee Meeting Date: 23 October 215 Ardea
More informationGout and Hyperuricemia
Gout and Hyperuricemia 100 Access publication Sep. 2016 Computed tomography manifestation of gouty arthritis Hu Yabin 1, Yang Qing 1, Cao Qiang 2, Ren Jianan 1, Yang Qing * Objective: Of the most commonly
More informationPATIENTS AND METHODS:
BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by erosive synovitis that involves peripheral joints and implicates an important influence in the quality
More informationChondrocalcinosis after parathyroidectomy*
Ann. rheum. Dis. (1976), 35, 521 Chondrocalcinosis after parathyroidectomy* J. S. GLASS AND R. GRAHAME From Guy's Arthritis Research Unit, Guy's Hospital Medical School, London SE] 9RT Glass, J. S., and
More informationA case of extensive synovial involvement by tophaceous gout
A case of extensive synovial involvement by tophaceous gout Nausheen Khan, MB BS, FCRad (D) Irma van de Werke, MB ChB, FRCR Farzanah Ismail, MB ChB, FCRad (D) Department of Radiology, Kalafong Hospital,
More informationAcute monoarthritis is a common clinical presentation
CMAJ Review Acute monoarthritis: What is the cause of my patient s painful swollen joint? Lingling Ma MD PhD, Ann Cranney MD MSc, Jayna M. Holroyd-Leduc MD DOI:10.1503/cmaj.080183 The case Early in the
More informationCrystal Deposition Disease. Donald J. Flemming, M.D. Department of Radiology Penn State Hershey Medical Center
Crystal Deposition Disease Donald J. Flemming, M.D. Department of Radiology Penn State Hershey Medical Center Crystals Basic Calcium Phosphate Hydroxyapatite Calcium Pyrophosphate Urate Basic Calcium Phosphate
More informationImplementing AHRQ Effective Health Care Reviews Helping Clinicians Make Better Treatment Choices
Implementing AHRQ Effective Health Care Reviews Helping Clinicians Make Better Treatment Choices Gout: Diagnosis and Management Practice Pointers by MATTHEW R. NOSS, DO, MSEd, U.S. Army Health Clinic,
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other PEGLOTICASE KRYSTEXXA 37154 GUIDELINES FOR USE 1. Does the patient have a diagnosis of symptomatic chronic gout (prior to initiating Krystexxa therapy) with clinical
More informationTherapy for Gout: The Past
Advances in Therapy for Gout: 2011 The Past, Present, and Future Therapy for Gout: The Past May 22, 1997 Pity a Tyrannosaur? Sue Had Gout By MALCOLM W. BROWNE Jonathan Graf, M.D. Associate Professor of
More informationLECTURE 5: DRUGS IN GOUT
Red : important Black : in male / female slides Pink : in female s slides only Blue : in male s slides only Green : Dr s notes Grey: Extra information, explanation Editing File LECTURE 5: DRUGS IN GOUT
More informationKrystexxa (pegloticase) Document Number: IC-0158
Krystexxa (pegloticase) Document Number: IC-0158 Last Review Date: 06/27/2017 Date of Origin: 02/07/20103 Dates Reviewed: 11/2013, 08/2014, 07/2015, 07/2016, 09/2016, 12/2016, 03/2017, 06/2017 I. Length
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acetaminophen, in neck pain, 505 506 Acupuncture, chi and, 524 for mechanical neck disorders, 525 in neck pain, 524 525 safety of, 525 Adson
More informationDose of celecoxib in gout attack attack
Dose of celecoxib in gout attack Gout is a disease characterized by an abnormal metabolism of uric acid, resulting in an excess of uric acid in the tissues and blood. People with gout either produce too
More informationPART MUSCULOSKELETAL DISORDERS
PART 12 MUSCULOSKELETAL DISORDERS CASE STUDY 77 GOUT For the Patient Case for this case study, see the printed book. DISEASE SUMMARY Definitions Gout is a syndrome of abnormal purine (i.e., DNA nucleotide
More informationGout: an Asia-Pacific update
International Journal of Rheumatic Diseases 2017; 20: 407 416 SPECIAL EDITORIAL REVIEW Gout: an Asia-Pacific update Binoy J. PAUL and Reeta JAMES Department of General Medicine, KMCT Medical College, Calicut,
More informationAchieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP
Achieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP Dr. Paul Doghramji is attending physician at the Pottstown Memorial Medical Center and medical director of Health Services
More informationGout: A Clinical Update. Why talk about Gout? Why talk about Gout? Populations at risk: Why is Gout Less Common in Women? US Gout Population: 2009
Gout: A Clinical Update Peng Thim Fan, MD, FACP Clinical Professor of Medicine Division of Rheumatology David Geffen School of Medicine at UCLA Why talk about Gout? Large increase in gout in the last 20
More informationClinical Policy Bulletin: Gout
Gout Page 1 of 13 Clinical Policy Bulletin: Gout Number: 0810 Policy Aetna considers the following tests medically necessary for the diagnosis of gout: Measurement of blood uric acid levels Measurement
More informationClass Update: Drugs for Gout
Copyright 2012 Oregon State University. ll Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationUltrasound in Rheumatology
Arthritis Research UK Primary Care Centre Winner of a Queen s Anniversary Prize For Higher and Further Education 2009 Ultrasound in Rheumatology Alison Hall Consultant MSK Sonographer/Research Fellow Primary
More informationTUMOR-LIKE SOFT TISSUE SWELLING OF THE DISTAL PHALANX DUE TO CALCIUM PYROPHOSPHATE DIHYDRATE CRYSTAL DEPOSITION
1428 BRIEF REPORT TUMOR-LIKE SOFT TISSUE SWELLING OF THE DISTAL PHALANX DUE TO CALCIUM PYROPHOSPHATE DIHYDRATE CRYSTAL DEPOSITION H. RALPH SCHUMACHER, JR., HUGH BONNER, JOHN J. THOMPSON, WALTER L. KESTER,
More informationUrate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout
Philippine Journal of Internal Medicine Meta-Analysis Urate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout Erika Bianca S. Villazor-Isidro, M.D.*; John Carlo G.
More informationjoint diseases By: Shefaa qa qa
joint diseases By: Shefaa qa qa Osteoarthritis degenerative joint disease characterized by degeneration of cartilage that results in structural and functional failure of synovial joints. It is the most
More information